Financing Climate-Resilient Healthcare in Viet Nam: From Risk Priorities to Accountable Investments

Financing Climate-Resilient Healthcare in Viet Nam: From Risk Priorities to Accountable Investments

IMPLEMENTATION INSIGHTS · CLIMATE-RESILIENT HEALTHCARE

Last reviewed: October 27, 2026

A hospital may already know that flooding could damage essential equipment, extreme heat could place additional pressure on cooling systems, or an interruption to electricity or water could disrupt clinical services. Its leadership may have identified vulnerable infrastructure and recognized the need for improvements. Yet understanding these risks is only the beginning. The more difficult decisions often emerge when the organization must determine what to address first and how to pay for it.

Healthcare organizations have competing priorities. Investments in climate resilience must be considered alongside medical equipment, workforce development, facility maintenance, digital systems, and improvements in clinical services. Even when the need for adaptation is clear, the most appropriate response may not be obvious. Should a hospital strengthen an existing system, invest in new infrastructure, improve maintenance arrangements, or establish additional operational safeguards?

These decisions involve more than the availability of funding. Healthcare leaders need to understand which vulnerabilities matter most for patient safety, what different interventions could realistically achieve, how much they would cost over time, and whether the organization has the authority and capacity to implement them.

For healthcare organizations in Viet Nam, financing climate resilience should therefore be understood as part of responsible healthcare governance and financial stewardship. The objective is not simply to obtain funding for climate-related projects. It is to direct appropriate resources toward investments that address meaningful risks, protect essential services, remain financially sustainable, and produce benefits that can be reasonably demonstrated.

Why Climate Resilience Requires Financial Planning

Climate-related disruption can impose costs on healthcare organizations that extend well beyond physical damage to buildings or equipment. An interruption to essential infrastructure may affect treatment schedules, staffing arrangements, patient transfers, medical supplies, and the resources required to restore normal operations. Depending on the circumstances, these consequences may continue after the immediate environmental event has passed.

Healthcare organizations also operate under conditions that differ from many other facilities. They may need to maintain essential services when external infrastructure is disrupted and when demand for care is increasing. A system that performs adequately during routine use may be unable to meet critical requirements during flooding, prolonged heat, or interruptions affecting electricity, water, or other essential utilities.

Investments intended to reduce these vulnerabilities may provide considerable value, but their financial benefits are not always straightforward to calculate. Unlike projects designed to expand revenue-generating services, resilience investments often produce benefits by reducing the likelihood or consequences of future disruption. Their value may become most apparent during events whose timing, severity, and frequency remain uncertain.

The World Health Organization's Operational Framework for Building Climate Resilient and Low Carbon Health Systems, published in November 2023, recognizes sustainable climate and health financing as one of ten interconnected components of stronger health systems. The framework emphasizes the importance of mobilizing resources, integrating climate considerations into health system planning, and supporting interventions that help protect health under changing climatic conditions.

This provides an important foundation for financial planning. Climate resilience should not be treated solely as an environmental initiative or a separate infrastructure program. Where climate-related risks could compromise essential healthcare services, investments to address those risks are closely connected to organizational governance, patient safety, service reliability, and long-term financial responsibility.

It is also important to distinguish climate adaptation from greenhouse gas emissions reduction. Some investments may support both objectives, but their expected benefits should be evaluated separately. An energy-efficient system does not necessarily provide reliable backup capacity during a power interruption, while infrastructure designed to withstand flooding may have little direct effect on emissions. A credible investment proposal should explain which risks and outcomes it is intended to address rather than rely on a general claim that a project is environmentally beneficial.

What Recent International Guidance Tells Us

Recent international publications have placed greater attention on the financial and institutional challenges of translating climate adaptation priorities into practical investments.

In October 2026, the Asian Development Bank (ADB) published Closing the Financing Gap for Climate-Resilient Health Systems: High-Level Health Care Climate Action Principle 4. The paper examines why financing for climate-resilient health systems remains fragmented, insufficient, and difficult to access, particularly in vulnerable settings.

It identifies five complementary strategies: strengthening institutions to mobilize and coordinate financing, aligning domestic public finance with health system resilience, improving access to international public finance, engaging the private sector to complement public resources, and deploying financing mechanisms suited to health system needs.

An important message is that financing challenges cannot be resolved through additional funding sources alone. Institutions must also be able to establish priorities, coordinate responsibilities, prepare credible investment proposals, and manage financial resources appropriately.

Another relevant development is WHO's Climate Finance for Healthier and More Resilient Societies: A Practical Brief for the Western Pacific Region, published on October 2, 2026. This regional publication examines how climate financing can support health outcomes within the health sector and across climate-sensitive sectors, including energy, water, transport, food systems, and urban development.

The brief highlights the importance of cross-sector collaboration, locally led approaches, investment readiness, and the identification of health benefits when developing climate-related investment proposals. Its regional perspective is particularly useful for understanding how health considerations can be incorporated into broader climate financing discussions.

ADB's Climate Adaptation Investment Planning: Lessons Learned, published in April 2026, and the subsequent Climate Adaptation Investment Planning Lessons Series No. 1 to 3, published in September 2026, provide further insights. Drawing on experience from Armenia, Bhutan, Cambodia, Indonesia, Mongolia, and Nepal, these publications examine how climate diagnostics, economic analysis, and financial matchmaking can help translate adaptation priorities into investment proposals.

Although these resources address different institutional and geographic contexts, they illustrate an important principle: identifying a climate-related risk does not automatically establish the best investment response, and developing an investment proposal does not guarantee access to financing.

WHO has also contributed to the measurement of climate-related action through its March 2026 publication, Indicators of Climate Resilience and GHG Emissions in Health Systems. The document proposes indicators across the ten components of WHO's operational framework, offering a reference for monitoring progress in climate resilience and emissions reduction.

These publications provide useful evidence and planning principles, but they should be interpreted according to their intended purposes. They do not establish funding entitlements for individual healthcare facilities in Viet Nam, replace national legal requirements, or constitute mandatory facility-level investment or accreditation standards.

Their value lies in helping decision-makers understand the relationships between climate risks, institutional capacity, financial resources, and measurable outcomes.

From Climate Risk Assessment to Investment Priorities

A climate risk assessment may identify numerous vulnerabilities within a healthcare organization. Some may concern physical infrastructure, while others involve essential utilities, supporting systems, workforce arrangements, or dependencies on external suppliers and services.

Not every vulnerability requires the same level of investment, and the most expensive asset is not necessarily the most important one to protect.

A useful starting point is to examine the consequences of failure. Which clinical services would be affected? Could patients experience significant harm or delays in necessary treatment? How quickly would the organization need to respond, and what alternatives would remain available?

The assessment should consider the likelihood and potential consequences of disruption, while recognizing the uncertainty associated with future climate conditions. Existing safeguards and the organization's capacity to recover are also important. A system exposed to a climate-related hazard may present a lower residual risk if effective protective measures and backup arrangements are already in place. Conversely, a seemingly minor supporting component may warrant greater attention when its failure could interrupt several essential services.

Consider a hypothetical hospital evaluating improvements to its electrical infrastructure. Several components may require maintenance or replacement, but their importance cannot be determined solely by purchase price or equipment age. A relatively inexpensive component supplying an essential treatment area may present greater patient safety consequences if it fails than a more costly asset whose interruption would have limited clinical effects.

The hospital would need to understand which services depend on each component, how existing backup systems perform, and whether alternative interventions could adequately reduce the risk.

Such an assessment may lead to several possible approaches. Depending on the circumstances, the organization might consider equipment replacement, protective modifications, improved maintenance, additional redundancy, or changes to contingency arrangements.

Comparing these alternatives is an essential part of investment prioritization. Purchasing new technology should not be treated as the preferred solution before the underlying problem and available options have been adequately understood.

Clinical leaders, quality and patient safety professionals, technical personnel, financial managers, and those responsible for organizational risk management each have relevant perspectives. Their involvement helps ensure that investment priorities reflect the consequences for healthcare delivery rather than only construction costs, equipment specifications, or the perceived attractiveness of a particular technology.

The aim is to reach a defensible decision about which interventions deserve attention first, recognizing that financial constraints may prevent every identified vulnerability from being addressed immediately.

Developing a Credible Investment Case

An identified investment need is not the same as an approved project. Before resources are committed, healthcare leaders should be able to explain what the proposed intervention is intended to achieve and why it represents a reasonable response to the identified risk.

A credible investment case begins with a clear description of the problem. It should identify the services or systems affected, the potential consequences of disruption, and the limitations of existing safeguards. Decision-makers should then examine reasonable alternatives, including targeted improvements to existing infrastructure, operational changes, additional protective measures, or larger capital investments.

The comparison should consider expected benefits, technical feasibility, implementation requirements, financial consequences, and the risks associated with each approach. It should also distinguish what is supported by available evidence from what remains uncertain.

The consequences of taking no additional action deserve attention. In some circumstances, existing arrangements may adequately control a lower-priority risk. In others, postponing an improvement could leave an essential service exposed to consequences that the organization considers unacceptable.

An intervention may appear attractive because it addresses several operational needs simultaneously. Yet its effectiveness may depend on complementary infrastructure, specialized technical support, staff capabilities, or changes to existing procedures. These dependencies should be understood before approval, particularly when they create continuing financial commitments.

The distinction between investment justification and financing is equally important. A project may be clinically justified but difficult to finance immediately. Another may be affordable while providing relatively limited protection against the organization's most consequential risks.

Responsible governance requires these differences to remain visible throughout the decision-making process. The purpose of an investment case is not to make every proposal appear financially attractive, but to provide a reliable basis for determining whether and how an intervention should proceed.

Looking Beyond the Initial Cost

The purchase price or construction budget represents only part of the financial commitment associated with a climate resilience investment.

Healthcare infrastructure and equipment often require inspection, maintenance, staff training, technical support, consumables, replacement components, utilities, and eventual renewal. Depending on the intervention, these expenses may continue for many years after the original project has been completed.

A lower-cost solution may appear attractive during procurement but become difficult to sustain if spare parts are unavailable, maintenance requirements are substantial, or specialist support is difficult to obtain. A more expensive alternative may offer better long-term value under some circumstances, but that conclusion requires appropriate analysis.

Lifecycle costing can help organizations understand the financial implications of acquiring, operating, maintaining, and replacing an asset or system throughout its expected service life. For climate resilience investments, this assessment may also need to examine how the proposed intervention would perform under the conditions it is intended to address.

An infrastructure improvement that works reliably during normal operations may offer limited protection if it cannot withstand a relevant extreme weather event. Its value therefore depends not only on ordinary performance but also on whether it can provide the intended protection when needed.

Future costs and benefits will remain uncertain. Equipment prices, maintenance requirements, climate conditions, healthcare demand, and financing arrangements may change during the investment period.

Estimates of avoided losses can be useful, but they should not be represented as guaranteed savings. Their validity depends on assumptions about future events and the effectiveness of the intervention in reducing their consequences.

Where uncertainty could materially affect the decision, comparing plausible scenarios and testing important assumptions may be more useful than relying on a single financial projection or return-on-investment estimate.

The central question is whether the organization can afford not only to implement the proposed improvement but also to maintain its intended function over time.

Economic Value, Financial Affordability, and Patient Safety

An investment can provide substantial benefits to patients and society without generating enough direct financial savings to recover its cost.

Preventing interruption to an essential healthcare service may help protect access to treatment and reduce the potential for avoidable harm. These benefits may be particularly important for patients who have limited alternatives when a facility becomes unavailable.

Economic evaluation can consider broader consequences, including health benefits, avoided losses, and the opportunity costs of alternative investments. Financial analysis addresses a different question: whether the organization has the resources to fund the intervention and sustain its operation.

A hospital may identify an investment with considerable potential health benefits but lack an available budget or suitable financing arrangement. Another project may generate measurable operating savings while contributing less to the protection of essential clinical services.

Neither financial payback nor economic value should therefore be treated as a substitute for assessing clinical importance.

Depending on the intervention and available evidence, cost-benefit analysis, cost-effectiveness analysis, or other structured approaches may help decision-makers compare alternatives. The choice of method should reflect the purpose of the assessment and the reliability of the available information.

Not every healthcare organization has the data or expertise required for sophisticated economic modeling. A proportionate evaluation with transparent assumptions may be more informative than an elaborate calculation based on limited evidence.

Financial constraints also raise questions of equity. Healthcare facilities serve populations with different needs, vulnerabilities, and access to alternative services. Disruption at a facility serving an isolated or underserved community may have consequences that are not fully captured by the replacement value of its physical assets.

Investment decisions should therefore consider patient needs, service dependence, and potential effects on healthcare access alongside economic and financial considerations.

This does not mean that every healthcare organization should receive the same level of investment. It means that differences in vulnerability, service importance, financial capacity, and available alternatives deserve appropriate consideration when limited resources are allocated.

Choosing Appropriate Financing Arrangements in Viet Nam

Healthcare organizations in Viet Nam operate under different ownership, governance, and financial arrangements. These differences influence which investments can be undertaken, how they may be financed, and what approvals or procedures may be required.

Public hospitals, private hospitals, clinics, and other healthcare providers do not necessarily have the same access to capital or authority to commit resources. Even within the public healthcare sector, financial autonomy classifications, institutional responsibilities, and permitted funding sources may differ.

For public healthcare organizations, climate resilience investment planning may involve state budget arrangements, authorized institutional resources, public investment requirements, procurement procedures, and rules governing public assets.

A proposed improvement may be important for patient safety without being eligible for financing from every source available to the institution. The legal basis for using particular funds must be established according to the actual organization and activity.

Private healthcare organizations may have greater flexibility in certain investment decisions, but they remain subject to corporate, financial, investment, construction, healthcare, and other applicable requirements. Depending on their circumstances, they may consider internal resources, borrowing, contractual arrangements, or other lawful financing mechanisms.

Commercial financing introduces obligations that require careful assessment. A resilience investment may reduce operational vulnerability without producing additional revenue, while debt repayment and financing costs may continue regardless of whether the anticipated benefits become immediately visible.

External grants, development assistance, concessional financing, guarantees, and other mechanisms may be relevant to particular programs or projects. However, each has its own objectives, institutional arrangements, eligibility criteria, financial conditions, and accountability requirements.

Some international financing mechanisms are intended primarily for governments, accredited entities, or other eligible implementing organizations. Individual healthcare facilities should not assume that an adaptation project qualifies for direct international funding simply because it addresses climate-related risks.

The WHO Western Pacific climate finance brief and ADB's October 2026 financing paper help explain the importance of investment readiness, institutional capacity, and matching financing instruments to the needs of the intended intervention. They do not constitute financing offers or guarantees that particular healthcare facilities can obtain grants or loans.

For many organizations, a practical first step may be to integrate climate resilience considerations into existing capital planning, maintenance budgets, and asset replacement programs. This can help institutions address meaningful vulnerabilities without assuming that improvements must depend entirely on a separate climate financing initiative.

The appropriate arrangement will ultimately depend on the nature of the investment, the organization's financial circumstances, its legal status, and the requirements attached to the proposed funding source.

The Vietnamese Policy and Legal Context

Viet Nam has established national policies addressing climate adaptation, environmental protection, healthcare development, and the management of public resources. These provide an important context for climate-resilient healthcare, although they do not establish a single financing mechanism applicable to every hospital or clinic.

Prime Minister's Decision No. 1422/QD-TTg, dated November 19, 2024, issued the updated National Climate Change Adaptation Plan for 2021–2030, with a vision to 2050. The Plan addresses adaptive capacity, vulnerability reduction, and measures intended to limit losses associated with climate change and extreme events.

This national policy direction supports greater attention to climate-related risks in long-term institutional planning. Nevertheless, inclusion within a national adaptation priority does not automatically establish funding eligibility, investment authority, or project approval for an individual healthcare organization.

For projects involving state budget resources, the Law on State Budget No. 89/2025/QH15, effective January 1, 2026, provides an important legal framework. Government Decree No. 73/2026/ND-CP, dated March 10, 2026, establishes detailed provisions and implementation guidance for selected provisions of the Law.

Public investment activities must also be considered under the Law on Public Investment No. 58/2024/QH15, effective January 1, 2025, as subsequently amended. Consolidated Document No. 03/VBHN-VPQH, dated February 5, 2026, provides a consolidated reference for the public investment legislation as amended up to the date of consolidation.

These frameworks are relevant to determining the appropriate use of public resources, investment responsibilities, and applicable approval and management procedures. Their application depends on the legal characteristics of the proposed project and its funding arrangements.

Public healthcare institutions may also be subject to the framework for financial autonomy of public service units established by Government Decree No. 60/2021/ND-CP, as amended by Decree No. 111/2025/ND-CP, effective July 7, 2025.

Financial autonomy must be understood in relation to the institution's assigned classification, lawful funding sources, financial obligations, and applicable sector-specific requirements. It should not be interpreted as unrestricted authority to use public resources for any project considered beneficial.

Procurement and public asset management introduce further considerations. The Law on Bidding No. 22/2023/QH15, as amended, provides a principal legal framework for activities within its scope. Consolidated Document No. 74/VBHN-VPQH, dated March 25, 2026, is a relevant reference for the amended legislation.

The applicable procurement route must be established according to the organization, transaction, funding source, and legal provisions in force at the relevant time. Proposed legislative amendments should not be treated as enacted requirements before they have been formally adopted and become applicable.

Projects involving construction or substantial modifications to infrastructure may also be subject to the Law on Construction No. 135/2025/QH15, effective July 1, 2026, subject to the Law's specific provisions and transitional arrangements.

The legal classification of a proposed activity matters. An equipment purchase, maintenance agreement, building modification, externally funded intervention, and formal public investment project may be subject to different requirements.

Public-private cooperation requires similar care. The Law on Public-Private Partnership Investment No. 64/2020/QH14, as amended, provides the framework for qualifying PPP investments. Consolidated Document No. 81/VBHN-VPQH, dated March 26, 2026, is a relevant consolidated reference. Government Decree No. 377/2026/ND-CP, effective October 1, 2026, further amended provisions of decrees implementing the PPP framework.

Not every arrangement involving a public healthcare institution and a private organization constitutes a formal PPP. Procurement contracts, service agreements, sponsorships, donations, and other forms of cooperation must be distinguished according to their actual legal nature and applicable requirements.

Healthcare-specific responsibilities remain central to investment decisions. The Law on Medical Examination and Treatment No. 15/2023/QH15, effective January 1, 2024, as amended, provides an overarching framework for healthcare activities. Consolidated Document No. 26/VBHN-VPQH, dated February 26, 2026, is a relevant consolidated reference.

Climate resilience interventions affecting clinical services should therefore be assessed with appropriate attention to healthcare quality, patient safety, professional responsibilities, and the conditions necessary for safe service delivery.

These legal frameworks serve different purposes and cannot be replaced by international financing guidance or general climate policy objectives. The existence of a desirable adaptation outcome does not, by itself, authorize a particular expenditure, procurement procedure, partnership, or investment arrangement.

Consolidated legal documents are useful references to legislation as amended, but they should not be confused with independently enacted laws or assumed to incorporate changes made after their consolidation dates.

For healthcare leaders, the practical implication is to establish the legal and financial basis of a proposed project before committing resources, involving appropriately qualified professionals whenever specialized assessment or formal approval is required.

Financing Implementation, Not Just Physical Assets

An approved investment may still fail to achieve its intended benefits if the organization cannot implement, operate, or maintain it effectively.

A hospital may secure funding for an infrastructure upgrade and complete the planned installation, only to discover that operating procedures require revision, staff need additional training, or the new equipment depends on technical support that is not readily available. These challenges may be particularly consequential when investments affect essential healthcare systems.

A technically suitable intervention can introduce additional dependencies, including specialized components, digital connectivity, maintenance contracts, or external suppliers. Such dependencies do not necessarily make a project inappropriate, but they need to be understood and managed.

Implementation itself can also create operational and patient safety risks. Construction work, equipment replacement, or changes to essential infrastructure may require temporary adjustments to clinical services. Depending on the project, appropriate safeguards and continuity arrangements may be needed during installation and commissioning.

For significant interventions, performance verification, staff training, documentation, maintenance arrangements, and formal handover can help establish whether the new or modified system is ready for use.

The level of assurance should reflect the complexity of the intervention and the potential consequences of failure. An improvement affecting essential clinical infrastructure may require substantially greater technical oversight than a modest operational change.

Financial planning should therefore include the resources needed for implementation, integration, training, maintenance, and ongoing support. The organization should also understand the responsibilities of suppliers, contractors, technical personnel, and managers throughout the expected operating life of the intervention.

A completed procurement process demonstrates progress toward acquiring goods, works, or services, but it does not, on its own, establish that the investment has improved resilience.

Measuring Results and Demonstrating Accountability

Healthcare organizations should be able to explain not only how much they invested, but also what the investment achieved.

This requires distinguishing project completion from operational performance and broader outcomes.

Project completion may be assessed through expenditure records, installation, contractual deliverables, and handover documentation. Operational performance requires different evidence, such as maintenance records, technical verification, functional testing, and the continued ability of a system to perform its intended purpose.

Where investments affect essential clinical services, organizations may also consider appropriate measures of service availability, reliability, and patient safety.

For example, an intervention intended to strengthen backup power reliability could be evaluated through documented testing under relevant operating conditions, verification of essential power capacity, maintenance performance, and the organization's ability to respond to interruptions.

These measures are illustrative rather than universally prescribed indicators. Their selection should reflect the particular system, associated clinical risks, relevant technical requirements, and information reasonably available to the organization.

WHO's March 2026 publication on climate resilience and greenhouse gas emissions indicators offers a useful international reference for strengthening measurement. However, indicators developed for health systems should not automatically be interpreted as mandatory facility-level measures or proof of compliance with a particular standard.

An important limitation is that climate-related benefits may be difficult to observe directly. The absence of a service interruption following an investment does not necessarily demonstrate that the intervention prevented a failure. The facility may simply not have experienced conditions severe enough to test the new safeguards.

Similarly, successful performance during normal operations does not establish that an intervention will function adequately under every possible extreme event.

Claims about avoided losses, reduced vulnerability, operational improvements, or financial savings should therefore be supported by suitable evidence and clearly stated assumptions. Estimated benefits should be distinguished from verified performance and observed outcomes.

Accountability also depends on maintaining clear responsibilities. Governing bodies and responsible managers should understand who oversees implementation, how important risks and deviations are addressed, and whether ongoing costs remain manageable.

When projects receive external financing, applicable reporting, contractual, environmental, social, or other accountability obligations must also be considered.

The level of assessment should remain proportionate to the project. A relatively small operational improvement does not necessarily require the same depth of analysis as a major capital investment. Nevertheless, both benefit from clear objectives, appropriate oversight, and an understanding of whether the intervention delivered its intended value.

This approach helps turn individual investments into opportunities for organizational learning rather than treating financial approval or project completion as the final measure of success.

Managing Long-Term Uncertainty

Climate resilience investments often involve systems expected to remain in use for many years. During that period, climate conditions, healthcare needs, technological options, operating expenses, and regulatory requirements may change.

No investment appraisal can eliminate these uncertainties.

Decision-makers should therefore consider whether a proposed intervention is likely to remain useful across a reasonable range of plausible future conditions. Flexibility, maintainability, compatibility with existing systems, and the possibility of future adaptation can be important considerations.

In some circumstances, staged investment may help an organization address urgent vulnerabilities while preserving flexibility for later improvements. Such an approach may be appropriate when the benefits of additional expenditure depend on future conditions or when resources are limited.

However, delaying investment also has potential consequences. Where a serious and inadequately controlled patient safety risk is already present, postponement could leave an essential service exposed. Any decision to defer action should therefore consider the severity of the risk, available safeguards, and the consequences of continued vulnerability.

Financial uncertainty deserves similar attention. Inflation, equipment replacement costs, maintenance requirements, and financing conditions may affect long-term affordability. Where these factors could substantially change the investment decision, alternative assumptions and sensitivity analysis may help clarify the implications.

The purpose is not to predict every future condition precisely. It is to make decisions that remain understandable, defensible, and capable of being reviewed as new information becomes available.

What Climate & Health Vietnam Can Contribute

For Climate & Health Vietnam (CHVN), financing climate-resilient healthcare is a relevant area for evidence synthesis, professional education, and implementation-oriented learning.

The subject connects climate adaptation with healthcare governance, patient safety, essential service continuity, financial stewardship, and the practical challenges of organizational improvement.

CHVN can contribute by examining credible international publications, explaining how climate risk priorities relate to investment decisions, and making relevant evidence more accessible to healthcare professionals and organizational leaders in Viet Nam.

An important area of professional learning is the distinction between recognizing a climate-related vulnerability, developing an investment justification, identifying an appropriate financing arrangement, and evaluating the results after implementation.

CHVN can also help professionals understand the limitations of published financial estimates, the importance of considering local conditions, and why an intervention with potential health or social value may not be immediately affordable or eligible for a particular financing mechanism.

Potential activities may include evidence summaries, educational resources, case-based discussions, and professional exchanges involving healthcare managers, clinicians, quality and patient safety specialists, engineers, financial professionals, researchers, and relevant institutional partners.

Where appropriate, CHVN may facilitate professional dialogue and knowledge-sharing collaboration with qualified academic, healthcare, technical, and other organizations interested in climate-resilient healthcare. Such activities should remain consistent with CHVN's actual expertise, institutional capacity, professional scope, and applicable legal requirements.

CHVN does not present international publications as its own official regulatory guidance or imply endorsement by WHO, ADB, or other organizations. It does not claim authority to approve investments, determine eligibility for public or international funding, arrange regulated financing, or guarantee access to grants or loans.

Where specialized project appraisal, financial modeling, engineering design, procurement, legal assessment, or regulated financial services are required, appropriately qualified and authorized professionals and organizations should be involved.

CHVN's contribution is to support a better understanding of the evidence, its relevance to healthcare in Viet Nam, and the professional considerations involved in making responsible investment decisions.

From Financial Commitment to Lasting Healthcare Resilience

Healthcare organizations cannot eliminate every climate-related risk, and few have sufficient resources to address every vulnerability at once. The challenge is to determine which improvements matter most, identify appropriate ways to finance them, and ensure that the benefits can be sustained over time.

A climate risk assessment can identify vulnerabilities, but it does not establish the best investment response. An approved budget can make implementation possible, but it does not guarantee technical effectiveness. A completed project can demonstrate that an intervention has been delivered, but it does not necessarily prove that the organization has become more resilient.

For healthcare organizations in Viet Nam, a practical starting point is to connect climate-related risk assessment with existing investment planning, financial oversight, quality management, and operational responsibilities.

Some facilities may require substantial capital investment. Others may achieve meaningful improvements through targeted upgrades, better maintenance, or changes to existing systems. The appropriate approach will depend on the risks involved, available resources, institutional capacity, and applicable legal requirements.

What matters is whether resources are directed toward credible priorities and whether the resulting improvements can reliably protect patients and essential healthcare services.

Ultimately, climate resilience financing should not be judged solely by the amount of money committed or the number of projects completed. Its value lies in whether healthcare organizations become better able to manage important risks, maintain essential services, and provide safe care under changing conditions.

Financing climate-resilient healthcare is not simply about finding money for climate projects. It is about making responsible investment decisions that protect essential services, support patient safety, and remain accountable for results long after the initial investment has been made.

Selected References and Policy Context

International Guidance and Evidence

World Health Organization. WHO Guidance for Climate-Resilient and Environmentally Sustainable Health Care Facilities. October 12, 2020.

World Health Organization. Operational Framework for Building Climate Resilient and Low Carbon Health Systems. November 9, 2023.

World Health Organization. Indicators of Climate Resilience and GHG Emissions in Health Systems. March 11, 2026.

World Health Organization, Regional Office for the Western Pacific. Climate Finance for Healthier and More Resilient Societies: A Practical Brief for the Western Pacific Region. October 2, 2026.

Asian Development Bank. Climate Adaptation Investment Planning: Lessons Learned. April 2026.

Asian Development Bank. Climate Adaptation Investment Planning Lessons Series No. 1 to 3. September 2026.

Karliner, J., Beyeler, N., Manyari, D. P., Banzon, E. P., Riley, B., and Coghlan, B. Closing the Financing Gap for Climate-Resilient Health Systems: High-Level Health Care Climate Action Principle 4. Asian Development Bank, Sustainable Development Working Papers. October 2026.

Viet Nam Policy and Regulatory Context

Prime Minister of Viet Nam. Decision No. 1422/QD-TTg, dated November 19, 2024, issuing the updated National Climate Change Adaptation Plan for 2021–2030, with a vision to 2050.

National Assembly. Law on State Budget No. 89/2025/QH15, effective January 1, 2026.

Government of Viet Nam. Decree No. 73/2026/ND-CP, dated March 10, 2026, detailing and guiding the implementation of selected provisions of the Law on State Budget.

National Assembly. Law on Public Investment No. 58/2024/QH15, effective January 1, 2025, as amended.

Office of the National Assembly. Consolidated Document No. 03/VBHN-VPQH, dated February 5, 2026, consolidating the Law on Public Investment.

Government of Viet Nam. Decree No. 60/2021/ND-CP on financial autonomy of public service units, as amended by Decree No. 111/2025/ND-CP, effective July 7, 2025.

National Assembly. Law on Bidding No. 22/2023/QH15, effective January 1, 2024, as amended.

Office of the National Assembly. Consolidated Document No. 74/VBHN-VPQH, dated March 25, 2026, consolidating the Law on Bidding.

National Assembly. Law on Public-Private Partnership Investment No. 64/2020/QH14, effective January 1, 2021, as amended.

Office of the National Assembly. Consolidated Document No. 81/VBHN-VPQH, dated March 26, 2026, consolidating the Law on Public-Private Partnership Investment.

Government of Viet Nam. Decree No. 377/2026/ND-CP, dated October 1, 2026, amending selected provisions of decrees implementing the Law on Public-Private Partnership Investment.

National Assembly. Law on Construction No. 135/2025/QH15, dated December 10, 2025, effective July 1, 2026, subject to its specific provisions and transitional arrangements.

National Assembly. Law on Medical Examination and Treatment No. 15/2023/QH15, effective January 1, 2024, as amended.

Office of the National Assembly. Consolidated Document No. 26/VBHN-VPQH, dated February 26, 2026, consolidating the Law on Medical Examination and Treatment.

Professional scope: This article is intended for professional education, evidence synthesis, and knowledge sharing. It does not constitute legal, financial, investment, tax, accounting, procurement, engineering, or individualized clinical advice; an investment feasibility study; a funding eligibility assessment; a formal climate risk assessment; a regulatory compliance determination; or accreditation or certification criteria. The investment considerations and illustrative examples discussed are not recommendations to adopt a particular financial instrument, undertake a specific project, alter clinical services, or enter into a contractual arrangement. References to WHO, ADB, and other international organizations do not imply their endorsement of Climate & Health Vietnam or its activities. CHVN does not claim authority to approve investments, allocate public funding, provide regulated financial intermediation, or guarantee access to grants or loans. Healthcare organizations should evaluate proposed investments according to their actual circumstances, applicable Vietnamese laws, institutional responsibilities, and advice from appropriately qualified and authorized professionals.